180 related articles for article (PubMed ID: 21215619)
1. Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2.
Klöck C; Jin X; Choi K; Khosla C; Madrid PB; Spencer A; Raimundo BC; Boardman P; Lanza G; Griffin JH
Bioorg Med Chem Lett; 2011 May; 21(9):2692-6. PubMed ID: 21215619
[TBL] [Abstract][Full Text] [Related]
2. An unprecedented dual antagonist and agonist of human Transglutaminase 2.
Yi MC; Palanski BA; Quintero SA; Plugis NM; Khosla C
Bioorg Med Chem Lett; 2015 Nov; 25(21):4922-4926. PubMed ID: 26004580
[TBL] [Abstract][Full Text] [Related]
3. Cinnamoyl inhibitors of tissue transglutaminase.
Pardin C; Pelletier JN; Lubell WD; Keillor JW
J Org Chem; 2008 Aug; 73(15):5766-75. PubMed ID: 18582115
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase.
Hausch F; Halttunen T; Mäki M; Khosla C
Chem Biol; 2003 Mar; 10(3):225-31. PubMed ID: 12670536
[TBL] [Abstract][Full Text] [Related]
5. Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase.
Pardin C; Roy I; Lubell WD; Keillor JW
Chem Biol Drug Des; 2008 Sep; 72(3):189-96. PubMed ID: 18715232
[TBL] [Abstract][Full Text] [Related]
6. Dihydroisoxazole analogs for labeling and visualization of catalytically active transglutaminase 2.
Dafik L; Khosla C
Chem Biol; 2011 Jan; 18(1):58-66. PubMed ID: 21276939
[TBL] [Abstract][Full Text] [Related]
7. Role of transglutaminase 2 in celiac disease pathogenesis.
Klöck C; Diraimondo TR; Khosla C
Semin Immunopathol; 2012 Jul; 34(4):513-22. PubMed ID: 22437759
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles.
Watts RE; Siegel M; Khosla C
J Med Chem; 2006 Dec; 49(25):7493-501. PubMed ID: 17149878
[TBL] [Abstract][Full Text] [Related]
9. Photolabeling of tissue transglutaminase reveals the binding mode of potent cinnamoyl inhibitors.
Pardin C; Roy I; Chica RA; Bonneil E; Thibault P; Lubell WD; Pelletier JN; Keillor JW
Biochemistry; 2009 Apr; 48(15):3346-53. PubMed ID: 19271761
[TBL] [Abstract][Full Text] [Related]
10. Recent Progress in the Development of Transglutaminase 2 (TGase2) Inhibitors.
Song M; Hwang H; Im CY; Kim SY
J Med Chem; 2017 Jan; 60(2):554-567. PubMed ID: 28122456
[TBL] [Abstract][Full Text] [Related]
11. Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2.
Klöck C; Herrera Z; Albertelli M; Khosla C
J Med Chem; 2014 Nov; 57(21):9042-64. PubMed ID: 25333388
[TBL] [Abstract][Full Text] [Related]
12. Activation and inhibition of transglutaminase 2 in mice.
Dafik L; Albertelli M; Stamnaes J; Sollid LM; Khosla C
PLoS One; 2012; 7(2):e30642. PubMed ID: 22319575
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase as a therapeutic target for celiac disease.
Sulic AM; Kurppa K; Rauhavirta T; Kaukinen K; Lindfors K
Expert Opin Ther Targets; 2015 Mar; 19(3):335-48. PubMed ID: 25410283
[TBL] [Abstract][Full Text] [Related]
14. Transglutaminase 2 undergoes a large conformational change upon activation.
Pinkas DM; Strop P; Brunger AT; Khosla C
PLoS Biol; 2007 Dec; 5(12):e327. PubMed ID: 18092889
[TBL] [Abstract][Full Text] [Related]
15. Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2.
Choi K; Siegel M; Piper JL; Yuan L; Cho E; Strnad P; Omary B; Rich KM; Khosla C
Chem Biol; 2005 Apr; 12(4):469-75. PubMed ID: 15850984
[TBL] [Abstract][Full Text] [Related]
16. Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions.
Badarau E; Wang Z; Rathbone DL; Costanzi A; Thibault T; Murdoch CE; El Alaoui S; Bartkeviciute M; Griffin M
Chem Biol; 2015 Oct; 22(10):1347-61. PubMed ID: 26456735
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
Chrobok NL; Bol JGJM; Jongenelen CA; Brevé JJP; El Alaoui S; Wilhelmus MMM; Drukarch B; van Dam AM
PLoS One; 2018; 13(4):e0196433. PubMed ID: 29689097
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminase 2 inhibitors and their therapeutic role in disease states.
Siegel M; Khosla C
Pharmacol Ther; 2007 Aug; 115(2):232-45. PubMed ID: 17582505
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the development of tissue transglutaminase (TG2) inhibitors.
Badarau E; Collighan RJ; Griffin M
Amino Acids; 2013 Jan; 44(1):119-27. PubMed ID: 22160259
[TBL] [Abstract][Full Text] [Related]
20. Elevated transglutaminase 2 activity is associated with hypoxia-induced experimental pulmonary hypertension in mice.
DiRaimondo TR; Klöck C; Warburton R; Herrera Z; Penumatsa K; Toksoz D; Hill N; Khosla C; Fanburg B
ACS Chem Biol; 2014 Jan; 9(1):266-75. PubMed ID: 24152195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]